[HTML][HTML] In vitro biodistribution studies on clinically approved FGFR inhibitors ponatinib, nintedanib, erlotinib and the investigational inhibitor KP2692
O Dömötör, M Mathuber, CR Kowol - European Journal of Pharmaceutical …, 2024 - Elsevier
Binding towards human serum albumin (HSA) and α1-acid glycoprotein (AGP) of three
approved fibroblast growth factor receptor (FGFR) inhibitors ponatinib (PON), nintedanib …
approved fibroblast growth factor receptor (FGFR) inhibitors ponatinib (PON), nintedanib …
Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators
GM Housey, ME Balash - US Patent App. 18/197,361, 2024 - Google Patents
US20240125769A1 - Compounds and methods of identifying, synthesizing, optimizing and
profiling protein modulators - Google Patents US20240125769A1 - Compounds and …
profiling protein modulators - Google Patents US20240125769A1 - Compounds and …
Theramutein modulators
GM Housey - US Patent 11,925,647, 2024 - Google Patents
Related US Application Data continuation of application No. 16/656,271, filed on Oct. 17,
2019, now Pat. No. 10.806. 738, which is a continuation of application No. 15/789,476, filed …
2019, now Pat. No. 10.806. 738, which is a continuation of application No. 15/789,476, filed …
Theramutein modultors
GM Housey - US Patent App. 18/433,881, 2024 - Google Patents
Related US Application Data division of application No. 17/038353, filed on Sep. 30, 2020,
now Pat. No. 11,504.377, which is a con-tinuation of application No. 16/656,271, filed on …
now Pat. No. 11,504.377, which is a con-tinuation of application No. 16/656,271, filed on …